Gene: IQCG
Official Full Name: dynein regulatory complex subunit 9provided by HGNC
Gene Summary: Enables Hsp70 protein binding activity and calmodulin binding activity. Predicted to be involved in sperm axoneme assembly. Located in actin cytoskeleton and cytosol. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25091 | IQCG Knockout cell line (HeLa) | Human | IQCG | 1:3~1:6 | Negative | Online Inquiry |
KO25092 | IQCG Knockout cell line (HCT 116) | Human | IQCG | 1:2~1:4 | Negative | Online Inquiry |
KO25093 | IQCG Knockout cell line (HEK293) | Human | IQCG | 1:3~1:6 | Negative | Online Inquiry |
KO25094 | IQCG Knockout cell line (A549) | Human | IQCG | 1:3~1:4 | Negative | Online Inquiry |
IQCG Gene Knockout Cell Lines are expertly engineered cellular models featuring targeted disruptions in the IQCG gene, a critical component in various cellular processes, including cell division and signal transduction. These cell lines serve as an invaluable tool for researchers investigating gene function, cellular behavior, and the underlying mechanisms of disease pathology. Utilizing CRISPR-Cas9 technology, the IQCG Gene Knockout Cell Lines provide a precise and efficient method for gene editing, allowing researchers to create specific knockout mutations that can elucidate the role of IQCG in various biological contexts.
The primary function of these cell lines is to allow scientists to perform gene function studies and investigate the impacts of IQCG disruption on cellular processes such as proliferation, differentiation, and metabolic pathways. By comparing the knockout cells to their wild-type counterparts, researchers can uncover crucial insights into the gene’s involvement in normal physiology and its potential contributions to disease states, including cancer and neurodegeneration.
IOQCG Gene Knockout Cell Lines hold significant scientific importance within both research and clinical applications. They are instrumental in drug discovery, toxicology assessments, and preclinical studies aimed at understanding disease mechanisms. Their utilization accelerates the translational research process, potentially leading to novel therapeutic strategies and improved clinical outcomes.
Unlike traditional knockout methodologies, which may produce off-target effects or require complex breeding schemes, IQCG Gene Knockout Cell Lines provide a ready-to-use platform that ensures high specificity of gene disruption and reproducibility of experiments. Researchers can save considerable time and resources while achieving precise genetic modifications essential to their studies.
For researchers and clinicians keen on pushing the boundaries of genetic research and therapeutic development, the IQCG Gene Knockout Cell Lines represent a cutting-edge solution with the potential to transform our understanding of gene function. Backed by our extensive expertise in genetic engineering and cell line development, our commitment to quality and scientific rigor ensures that you receive reliable and effective tools to meet your research needs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.